New Transcription Factors and Their Role in Diabetes and Therapy
-10%
portes grátis
New Transcription Factors and Their Role in Diabetes and Therapy
Elsevier Science & Technology
06/2003
332
Dura
Inglês
9780444511584
15 a 20 dias
Descrição não disponível.
1. PPARs as therapeutic targets for treating diabetes and insulin resistance 2. Genetic regulators of human obesity and diabetes 3. NF-kb, insulin resistance and the actions of salicylates 4. Wnt signaling and C/EBPs role in adipogenesis 5. Regulation of hepatic gluconeogenesis C/EPBs 6. Forkhead proteins and regulation of hepatic gene expression 7. Control of mitochondrial biogenesis through PGC-1 8. Regulation of PGC-1 in humans in insulin resistance and diabetes: Functional implications 9. FOXC2 controls resistance to obesity and Type II diabetes 10. SREB-1C regulation of nutrient homeostasis and lipid accumulation 11. GATA proteins as molecular gatekeeprs of the adipocyte 12. Diabetes regulation of gene expression by CREB 13. Molecular etiologies of MODY and other early-onset forms of diabetes 14. Liver X receptors as potential drug targets for Diabetes and its disorders 15. The potential therapeutic use of PPAR beta/delta agonists in lipid and glucose homeostasis 16. Influences of new PPAR insulin sensitizers on the metabolic syndrome in Rhesus Monkeys 17. PPARgamma and metabolism: Insights from the study of human genetic variants
1. PPARs as therapeutic targets for treating diabetes and insulin resistance 2. Genetic regulators of human obesity and diabetes 3. NF-kb, insulin resistance and the actions of salicylates 4. Wnt signaling and C/EBPs role in adipogenesis 5. Regulation of hepatic gluconeogenesis C/EPBs 6. Forkhead proteins and regulation of hepatic gene expression 7. Control of mitochondrial biogenesis through PGC-1 8. Regulation of PGC-1 in humans in insulin resistance and diabetes: Functional implications 9. FOXC2 controls resistance to obesity and Type II diabetes 10. SREB-1C regulation of nutrient homeostasis and lipid accumulation 11. GATA proteins as molecular gatekeeprs of the adipocyte 12. Diabetes regulation of gene expression by CREB 13. Molecular etiologies of MODY and other early-onset forms of diabetes 14. Liver X receptors as potential drug targets for Diabetes and its disorders 15. The potential therapeutic use of PPAR beta/delta agonists in lipid and glucose homeostasis 16. Influences of new PPAR insulin sensitizers on the metabolic syndrome in Rhesus Monkeys 17. PPARgamma and metabolism: Insights from the study of human genetic variants
